NMADvsLIXT
NOMAD Power Solutions (formerly LIXTE Biotechnology) vs LIXTE Biotechnology
Side-by-side Ethereum treasury comparison: holdings, market cap, mNAV ratio, cost basis, and recent purchases. Numbers refresh every 5 minutes from SEC filings and live market data.
NMAD
NOMAD Power Solutions (formerly LIXTE Biotechnology)
🇺🇸 US
300 ETH
$575.9K market value
LIXT
LIXTE Biotechnology
🇺🇸 US
301 ETH
$577.2K market value
Metric
NMAD
LIXT
ETH holdings
300 ETH
301 ETH
Market value of ETH
$575.9K
$577.2K
Average cost per ETH
—
$2,953.00
Total cost basis
—
$885.9K
mNAV (market cap ÷ ETH value)
—
154.39×
Last disclosed purchase
—
May 14, 2026
Country
🇺🇸 US
🇺🇸 US
No tracked purchases yet
- May 14, 2026+0 ETH$831.6K
- Mar 31, 2026+0 ETH—
- Nov 24, 2025+301 ETH$885.9K
- Nov 12, 2025+0 ETH$1.4M
NMAD vs LIXT: frequently asked
Which company holds more Ethereum, NMAD or LIXT?▾
LIXTE Biotechnology (LIXT) holds 301 ETH, compared to NOMAD Power Solutions (formerly LIXTE Biotechnology)'s (NMAD) 300 ETH.
What's the total Ethereum value on the balance sheets of NMAD and LIXT?▾
NMAD holds $575.9K worth of Ethereum at current market prices. LIXT holds $577.2K.
Who has a lower cost basis per ETH, NMAD or LIXT?▾
Cost basis disclosure is inconsistent across these two entities; check each company's detail page for per-purchase history.
When did NMAD last buy Ethereum?▾
NMAD's last ETH move isn't in our tracked history yet.
When did LIXT last buy Ethereum?▾
LIXT's most recent ETH disclosure on May 14, 2026 was a balance-sheet update, not a buy or sale.